- Home
- CMND vs SYRS Comparison
CMND vs SYRS Comparison
Compare CMND & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMND
- SYRS
- Stock Information
- Founded
- CMND 2017
- SYRS 2011
- Country
- CMND Canada
- SYRS United States
- Employees
- CMND N/A
- SYRS N/A
- Industry
- CMND Biotechnology: Pharmaceutical Preparations
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- CMND Health Care
- SYRS Health Care
- Exchange
- CMND Nasdaq
- SYRS Nasdaq
- Market Cap
- CMND 7.5M
- SYRS 7.1M
- IPO Year
- CMND N/A
- SYRS 2016
- Fundamental
- Price
- CMND $1.49
- SYRS $0.22
- Analyst Decision
- CMND
- SYRS Hold
- Analyst Count
- CMND 0
- SYRS 5
- Target Price
- CMND N/A
- SYRS $3.00
- AVG Volume (30 Days)
- CMND 2.9M
- SYRS 3.2M
- Earning Date
- CMND 01-28-2025
- SYRS 10-31-2024
- Dividend Yield
- CMND N/A
- SYRS N/A
- EPS Growth
- CMND N/A
- SYRS N/A
- EPS
- CMND N/A
- SYRS N/A
- Revenue
- CMND N/A
- SYRS $386,000.00
- Revenue This Year
- CMND N/A
- SYRS N/A
- Revenue Next Year
- CMND N/A
- SYRS N/A
- P/E Ratio
- CMND N/A
- SYRS N/A
- Revenue Growth
- CMND N/A
- SYRS N/A
- 52 Week Low
- CMND $0.92
- SYRS $0.18
- 52 Week High
- CMND $2.30
- SYRS $7.96
- Technical
- Relative Strength Index (RSI)
- CMND 52.63
- SYRS 37.85
- Support Level
- CMND $1.41
- SYRS $0.20
- Resistance Level
- CMND $1.62
- SYRS $0.25
- Average True Range (ATR)
- CMND 0.13
- SYRS 0.04
- MACD
- CMND 0.00
- SYRS 0.03
- Stochastic Oscillator
- CMND 33.33
- SYRS 21.90
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.